Back to search
Primary Ovarian Leiomyosarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Ovarian Leiomyosarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Ovarian Leiomyosarcoma trials you may qualify forThis observational study aims to gather comprehensive data on primary ovarian leiomyosarcoma (POLMS). This extremely rare malignancy accounts for less than 3% o…
The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with…
A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homolo…
RATIONALE: Antiemetic drugs may help to reduce or prevent vomiting in patients treated with radiation therapy. It is not yet known if ondansetron is more effect…
Exploratory study to examine the effect(s) of Imatinib mesylate treatment on life threatening rare diseases with known associations to one or more Imatinib mesy…